Palvella Therapeutics (PVLA) Research & Development (2014 - 2026)
Palvella Therapeutics' Research & Development was $12.47 million in Q2 2026, up 143.7% from $5.12 million a year earlier and up 33.6% from the prior quarter.
Powered by 
Analysis
Palvella Therapeutics (PVLA) Research & Development (2014 - 2026) Analysis & Trends
On a trailing twelve-month basis, Palvella Therapeutics' Research & Development was $35.46 million through Jun 30, 2026, up 137.7% year-over-year; for FY2025, it was $22.84 million, up 180.2% from FY2024.
- Research & Development shows a five-year compound annual growth rate of -13.3% (FY2020 to FY2025).
- In earlier years, Research & Development was $8.15 million in FY2024 (-7.3%), $8.79 million in FY2023 (-83.4%), $52.98 million in FY2022 (-20.5%) and $66.66 million in FY2021 (+43.3%).
- The Q2 2026 figure marks the highest quarterly Research & Development since Q2 2023.
- Compared with a year earlier, Research & Development has increased for six straight quarters, with growth averaging 151.4% over the last seven quarters.
- The best year-over-year quarter for Research & Development over five years was Q1 2025 (growth of 314.0%); the worst was Q1 2024 (a decline of 92.7%).
- Per Business Quant data, PVLA's Research & Development in the three quarters before Q2 2026 was $9.33 million (Q1 2026), $7.12 million (Q4 2025) and $6.53 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 3.02 Bn |
| 10 | Palvella Therapeutics | 2.38 Bn | 2.13 Bn | - | 12.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.47 Mn |
| Mar 31, 2026 | 9.33 Mn |
| Dec 31, 2025 | 7.12 Mn |
| Sep 30, 2025 | 6.53 Mn |
| Jun 30, 2025 | 5.12 Mn |
| Mar 31, 2025 | 4.07 Mn |
| Dec 31, 2024 | 2.54 Mn |
| Sep 30, 2024 | 3.18 Mn |
| Jun 30, 2024 | 1.44 Mn |
| Mar 31, 2024 | 984,000.00 |
| Dec 31, 2023 | -28.55 Mn |
| Sep 30, 2023 | 9.60 Mn |
| Jun 30, 2023 | 14.33 Mn |
| Mar 31, 2023 | 13.42 Mn |
| Dec 31, 2022 | 13.38 Mn |
| Sep 30, 2022 | 13.59 Mn |
| Jun 30, 2022 | 11.95 Mn |
| Mar 31, 2022 | 14.07 Mn |
| Dec 31, 2021 | 15.36 Mn |
| Sep 30, 2021 | 18.94 Mn |
API Access
Palvella Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=PVLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "PVLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=PVLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();